47 related articles for article (PubMed ID: 2666332)
1. Detecting chloroquine retinopathy: electro-oculogram versus colour vision.
Neubauer AS; Samari-Kermani K; Schaller U; Welge-Lübetaen U; Rudolph G; Berninger T
Br J Ophthalmol; 2003 Jul; 87(7):902-8. PubMed ID: 12812896
[TBL] [Abstract][Full Text] [Related]
2. The Royal College of Ophthalmologists recommendations on monitoring for hydroxychloroquine and chloroquine users in the United Kingdom (2020 revision): executive summary.
Yusuf IH; Foot B; Lotery AJ
Eye (Lond); 2021 Jun; 35(6):1532-1537. PubMed ID: 33423043
[No Abstract] [Full Text] [Related]
3. Is COVID-19 Infection a Trigger for Herpetic Stromal Keratitis?
Yildiz BK; Ozkan D; Tellioglu A; Demirok A
Beyoglu Eye J; 2022; 7(2):140-142. PubMed ID: 35692270
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of Maculopathy in Patients Using Hydroxychloroquine.
Uğurlu A; Aslanova M; Cebeci Z; Kır Mercül N
Turk J Ophthalmol; 2019 Jun; 49(3):149-153. PubMed ID: 31245977
[TBL] [Abstract][Full Text] [Related]
5. Current and Future Use of Chloroquine and Hydroxychloroquine in Infectious, Immune, Neoplastic, and Neurological Diseases: A Mini-Review.
Plantone D; Koudriavtseva T
Clin Drug Investig; 2018 Aug; 38(8):653-671. PubMed ID: 29737455
[TBL] [Abstract][Full Text] [Related]
6. Ocular toxicity due to chloroquine and hydroxychloroquine: electrophysiological and visual function correlates.
Tzekov R
Doc Ophthalmol; 2005 Jan; 110(1):111-20. PubMed ID: 16249962
[TBL] [Abstract][Full Text] [Related]
7. Ocular toxicity of hydroxychloroquine.
Tehrani R; Ostrowski RA; Hariman R; Jay WM
Semin Ophthalmol; 2008; 23(3):201-9. PubMed ID: 18432546
[TBL] [Abstract][Full Text] [Related]
8. Ophthalmologic considerations in using antimalarials in the United States.
Rynes RI
Lupus; 1996 Jun; 5 Suppl 1():S73-4. PubMed ID: 8803917
[TBL] [Abstract][Full Text] [Related]
9. Ocular effects and safety of antimalarial agents.
Easterbrook M
Am J Med; 1988 Oct; 85(4A):23-9. PubMed ID: 3177429
[TBL] [Abstract][Full Text] [Related]
10. [Chloroquine retinopathy].
François J; de Rouck A; Cambie E; de Laey JJ
Ophthalmologica; 1972; 165(2):81-99. PubMed ID: 4539289
[No Abstract] [Full Text] [Related]
11. Screening for antimalarial toxicity.
Easterbrook M
Can J Ophthalmol; 1993 Apr; 28(2):51-2. PubMed ID: 8508335
[No Abstract] [Full Text] [Related]
12. Retinal toxicity associated with hydroxychloroquine and chloroquine: risk factors, screening, and progression despite cessation of therapy.
Michaelides M; Stover NB; Francis PJ; Weleber RG
Arch Ophthalmol; 2011 Jan; 129(1):30-9. PubMed ID: 21220626
[TBL] [Abstract][Full Text] [Related]
13. The Demise of the Bull's Eye (Screening for Hydroxychloroquine Retinopathy).
Marmor MF
Retina; 2016 Oct; 36(10):1803-5. PubMed ID: 27388736
[No Abstract] [Full Text] [Related]
14. Complications of antimalarial therapy.
Lozier JR; Friedlaender MH
Int Ophthalmol Clin; 1989; 29(3):172-8. PubMed ID: 2666332
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
